Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Other financing activities (2020 - 2025)

Palisade Bio (PALI) has disclosed Other financing activities for 5 consecutive years, with $178000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Other financing activities changed N/A to $178000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $298000.0, a 41.11% decrease, with the full-year FY2024 number at $576000.0, down 6.65% from a year prior.
  • Other financing activities was $178000.0 for Q1 2025 at Palisade Bio, up from $120000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $413000.0 in Q1 2023 to a low of $15000.0 in Q3 2023.
  • A 5-year average of $173750.0 and a median of $129500.0 in 2023 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 768.75% in 2023; the steepest drop was 95.27% in 2023.
  • Palisade Bio's Other financing activities stood at $87000.0 in 2021, then skyrocketed by 237.93% to $294000.0 in 2022, then crashed by 82.99% to $50000.0 in 2023, then skyrocketed by 140.0% to $120000.0 in 2024, then skyrocketed by 48.33% to $178000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other financing activities are $178000.0 (Q1 2025), $120000.0 (Q4 2024), and $68000.0 (Q3 2024).